7Baggers
Quarterly
Annual
    Unit: USD2025-09-27 2025-06-28 2025-03-29 2024-12-31 2024-09-28 2024-06-29 2024-03-30 2023-12-31 2023-09-30 2023-07-01 2023-04-01 2022-12-31 2022-10-01 2022-07-02 2022-04-02 2021-12-31 2021-10-02 2021-07-03 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 
      
    		                                                         
      operating activities
    		                                                -14,700,000 -300,000 -3,400,000 1,500,000 -1,000,000     
      income from continuing operations attributable to itt inc.
    		127,000,000 121,000,000 108,400,000 126,900,000 161,300,000 119,200,000 111,000,000 92,400,000 110,800,000 108,200,000 100,000,000 115,200,000 102,500,000 75,800,000 74,800,000 103,000,000 86,600,000 39,000,000 86,200,000 -13,600,000 -48,000,000 46,400,000 83,700,000 66,500,000 118,700,000 66,900,000 71,300,000 50,600,000 111,000,000 69,700,000 101,100,000 -66,000,000 87,000,000 47,900,000 46,100,000 23,600,000 88,300,000                     
      adjustments to income from continuing operations:
    		                                                         
      depreciation and amortization
    		35,200,000 35,500,000 37,200,000 36,600,000 34,700,000 32,400,000 33,600,000 26,400,000 29,000,000 27,100,000 26,700,000 25,900,000 26,200,000 28,000,000 27,300,000 27,800,000 28,100,000 28,700,000 28,500,000 30,200,000 27,500,000 27,100,000 27,400,000 32,300,000 28,100,000 26,600,000 26,400,000 26,900,000 27,300,000 27,600,000 27,600,000 27,700,000 27,200,000 25,600,000 24,800,000 25,500,000 25,400,000 25,800,000 25,300,000 26,900,000 21,200,000 21,200,000 20,700,000 24,100,000 22,000,000 21,100,000 21,100,000 20,400,000 21,900,000 19,400,000 17,700,000 17,000,000 17,000,000 -183,000,000 85,000,000 88,000,000 84,000,000 
      equity-based compensation
    		10,200,000 9,300,000 7,900,000 6,100,000 6,100,000 6,700,000 7,000,000 5,100,000 5,000,000 5,400,000 4,700,000 4,500,000 4,900,000 5,000,000 3,700,000 4,700,000 4,400,000 4,100,000 3,300,000 3,700,000 3,900,000 3,300,000 2,500,000 3,400,000 3,900,000 3,900,000 4,500,000 4,700,000 6,700,000 5,700,000 4,500,000                           
      gain on sale of business
    		        0                                                 
      other non-cash charges
    		13,400,000 7,900,000 6,300,000 6,700,000 8,100,000 7,600,000 8,100,000 14,600,000 5,900,000 9,100,000 7,500,000 7,300,000 2,900,000 7,100,000 10,200,000 3,400,000 6,700,000 4,900,000 6,300,000 11,500,000 10,000,000 12,500,000 11,000,000 13,000,000 10,500,000                                 
      changes in assets and liabilities:
    		                                                         
      change in receivables
    		-16,400,000 -8,400,000 -43,200,000 50,300,000 -33,100,000 7,300,000 -67,700,000 15,500,000 3,900,000 -23,900,000 -34,700,000 30,100,000 -43,200,000 -6,900,000 -70,700,000 800,000 -11,400,000 -1,500,000 -50,100,000 5,500,000 -19,400,000 110,600,000 -13,400,000  11,000,000 -5,800,000 -47,100,000  -8,300,000 -1,900,000 -13,300,000  -11,600,000 -900,000 -34,700,000 36,400,000 31,700,000 -24,600,000 -21,000,000  -5,400,000 -15,100,000 -56,700,000  -14,200,000 20,700,000 -100,000,000  -42,300,000 42,200,000 1,000,000 7,100,000 -68,000,000 179,000,000 -38,000,000 -113,000,000 -102,000,000 
      change in inventories
    		-2,100,000 -6,300,000 -5,600,000 4,600,000 2,500,000 -4,100,000 -1,000,000 6,500,000 -9,500,000 -2,300,000 -29,100,000 11,800,000 -4,800,000 -58,100,000 -48,400,000 -20,100,000 -11,800,000 -29,600,000 -21,200,000 22,700,000 11,800,000 1,400,000 600,000  -800,000 -10,100,000 -17,300,000  600,000 -2,100,000 -20,700,000 18,400,000 -6,500,000 3,900,000 -1,600,000  -5,200,000 300,000 -4,000,000 37,800,000 -8,300,000 -1,600,000 3,600,000  -12,100,000 -19,800,000 25,600,000  25,600,000 5,700,000 -6,300,000 2,900,000 -11,000,000 108,000,000 -47,000,000 -23,000,000 -76,000,000 
      change in contract assets
    		-8,700,000 600,000 -6,600,000 -2,900,000 15,700,000 -7,200,000 -13,500,000 -800,000 3,400,000 -900,000 -2,000,000 8,200,000 -4,700,000 -9,200,000 -1,700,000     -1,400,000    16,100,000                                  
      change in contract liabilities
    		8,900,000 18,900,000 15,900,000 700,000 -17,100,000 12,200,000 3,300,000 12,000,000 -900,000 9,100,000 2,900,000 -1,100,000 5,700,000 6,900,000 11,800,000     -3,600,000                                      
      change in accounts payable
    		-10,000,000 -25,800,000 16,500,000 13,200,000 -19,600,000 -6,800,000 15,000,000 9,800,000 7,600,000 7,100,000 1,800,000 -14,600,000 -11,300,000 16,700,000 48,600,000 29,500,000 16,000,000 -4,500,000 36,600,000 100,000 27,500,000 -55,900,000 -6,400,000  -7,800,000 -7,400,000 18,800,000  3,900,000 -24,600,000 10,400,000 13,400,000 11,200,000 -10,300,000 2,500,000 16,900,000 -11,900,000 10,500,000 -14,800,000 11,400,000 -4,900,000 5,000,000 -500,000  1,600,000 -2,200,000 1,800,000 100,000 -11,000,000 7,600,000 -16,400,000 -6,500,000 11,000,000 -133,000,000 25,000,000 125,000,000 -13,000,000 
      change in accrued expenses
    		27,300,000 23,300,000 -31,700,000 3,300,000 12,000,000 18,400,000 -44,500,000 18,200,000 13,900,000 26,300,000 -10,800,000 -6,300,000 2,400,000 9,500,000 -42,500,000 6,300,000 -3,400,000 27,400,000 -14,500,000 -11,000,000 9,500,000 30,900,000 -25,200,000  20,900,000 1,400,000 -29,500,000 13,000,000 15,700,000 8,200,000 -31,200,000 -1,100,000 21,600,000 200,000 -3,500,000  9,300,000 700,000 -28,800,000  -6,500,000 1,700,000 -21,300,000  7,600,000 6,000,000 -9,500,000 44,000,000 1,500,000 2,200,000 -3,600,000 5,300,000 -14,000,000     
      change in income taxes
    		-4,800,000 -16,400,000 11,800,000 13,300,000 -1,800,000 -23,700,000 10,100,000 7,500,000 6,000,000 -11,800,000 3,700,000 -1,400,000 -8,600,000 -13,600,000 10,100,000 -121,200,000 6,300,000 112,700,000 10,400,000 57,700,000 -46,400,000 -34,000,000 16,500,000  19,600,000 -5,800,000 9,500,000                               
      other
    		-6,100,000 -5,900,000 -3,500,000 -15,500,000 2,900,000 -4,300,000 -3,600,000 -16,300,000 -5,300,000 -6,500,000 -12,600,000 5,500,000 -11,000,000 -4,300,000 -25,900,000 -13,800,000 -7,400,000 -5,900,000 -15,500,000 -13,000,000 3,600,000 -7,200,000 -12,700,000 9,800,000 19,500,000 -26,900,000 -2,200,000 -5,000,000 9,000,000 10,600,000 -3,600,000  300,000 -3,100,000 -7,500,000 24,400,000 -8,200,000 3,800,000 -3,500,000 3,200,000 8,300,000 -100,000 -8,100,000 25,300,000 -2,200,000 13,600,000 -300,000 21,000,000 -21,300,000 19,500,000 -1,000,000 10,700,000 22,000,000 -59,000,000 136,000,000 -69,000,000 -61,000,000 
      net cash – operating activities
    		173,900,000 153,700,000 113,400,000 223,200,000 123,900,000 157,700,000 57,800,000 170,400,000 169,800,000 139,700,000 58,100,000 162,500,000 61,000,000 56,900,000 -2,700,000 119,500,000 103,700,000 -302,400,000 70,800,000 117,800,000 115,000,000 149,600,000 53,500,000 136,000,000 120,600,000 59,000,000 42,100,000 125,200,000 127,300,000 76,900,000 42,400,000 69,000,000 85,700,000 65,600,000 27,100,000 94,000,000 75,100,000 65,900,000 5,700,000 82,600,000 57,600,000 81,300,000 8,200,000 112,800,000 47,600,000 97,500,000 -13,200,000 128,000,000 29,800,000 70,000,000 74,000,000 85,100,000 18,000,000 -775,000,000 248,000,000 184,000,000 20,000,000 
      investing activities
    		                                                         
      capital expenditures
    		-27,700,000 -16,400,000 -36,800,000 -36,400,000 -36,600,000 -23,200,000 -27,700,000 -39,100,000 -22,200,000 -17,600,000 -28,700,000 -30,200,000 -26,200,000 -17,500,000 -30,000,000 -35,800,000 -17,500,000 -17,900,000 -17,200,000 -16,100,000 -13,300,000 -12,100,000 -22,200,000  -23,500,000 -16,600,000 -29,200,000  -17,500,000 -17,600,000 -28,700,000  -25,900,000 -16,600,000 -36,700,000  -22,000,000 -25,100,000 -21,000,000  -18,200,000 -15,800,000 -30,200,000  -28,700,000 -26,700,000 -19,000,000  -21,400,000 -39,900,000 -14,200,000 -16,700,000 -13,000,000 83,000,000 -63,000,000 -76,000,000 -47,000,000 
      free cash flows
    		                                                         
      proceeds from government incentives for capital expenditures
    		                                                         
      proceeds from sale of business, net of cash divested
    		                                                         
      acquisitions, net of cash acquired
    		0 1,700,000 -1,900,000 0 -457,300,000 100,000 -407,600,000 0 0   0 0       0 0 0 -4,700,000  -25,800,000        0 0 -113,700,000  -8,600,000 0 -200,000  0             293,000,000 -308,000,000   
      net cash – investing activities
    		-14,900,000 -16,300,000 -40,700,000 -23,300,000 -334,000,000 -25,300,000 -435,300,000 -39,000,000 -22,200,000 -91,300,000 -28,500,000 -10,300,000 -26,400,000 -189,000,000 -29,400,000 -28,400,000 -19,200,000 -17,600,000 -17,100,000 -15,400,000 -13,300,000 -10,900,000 -26,200,000  -48,500,000 -103,500,000 -28,800,000  24,300,000 -17,200,000 -28,200,000  -24,800,000 -14,400,000 -150,100,000  -25,700,000 28,000,000 -24,800,000  28,800,000 -100,200,000 -40,000,000  100,000 -59,100,000 26,500,000  -85,200,000 -232,100,000 -13,900,000 -16,700,000 -12,000,000 354,000,000 -362,000,000 -67,000,000 -32,000,000 
      financing activities
    		                                                         
      commercial paper, net borrowings
    		-29,300,000 -317,600,000 291,800,000 64,800,000 5,200,000 34,800,000 134,700,000  -143,300,000 11,800,000 -72,800,000 -103,400,000 -1,500,000 73,900,000 290,700,000 0 0 138,000,000 -42,600,000 -17,600,000 -20,300,000    -22,200,000       31,400,000 8,100,000 10,900,000 -1,500,000 -37,500,000 33,000,000 -5,000,000 28,500,000                   
      long-term debt issued, net of debt issuance costs
    		200,000   1,500,000 463,300,000 0 299,100,000                                                   
      long-term debt repayments
    		-45,100,000 -131,200,000 -229,300,000 -236,100,000                                                      
      share repurchases under repurchase plan
    		-100,000 -400,800,000 -100,000,000 -500,000 -25,000,000   0 0 -30,000,000 -30,000,000 300,000 -4,700,000 -77,000,000 -163,900,000                                           
      payments for taxes related to net share settlement of stock incentive plans
    		-300,000 -400,000 -13,000,000 -1,000,000 -400,000 -300,000 -12,500,000 -500,000 -300,000 -100,000 -6,300,000 -300,000                                              
      dividends paid
    		-27,300,000 -27,500,000 -28,700,000 -26,000,000 -26,100,000 -26,100,000 -26,500,000 -23,900,000 -23,800,000 -23,900,000 -24,200,000 -21,800,000 -21,800,000 -21,900,000 -22,400,000 -18,800,000 -18,900,000 -19,000,000 -19,100,000 -29,300,000 -15,100,000 -14,400,000 -200,000  0 -12,900,000 -13,200,000  -11,900,000 -11,800,000 -200,000  -11,200,000 -11,400,000 -200,000  -100,000 -11,100,000 -11,400,000  -10,600,000    -10,100,000    -9,000,000 -17,000,000 0 -8,200,000 -9,000,000 -9,000,000 -46,000,000 -46,000,000 -92,000,000 
      net cash – financing activities
    		-107,600,000 -128,700,000 -79,900,000 -197,100,000 218,200,000 -109,600,000 323,400,000 -87,100,000 -168,900,000 -43,400,000 -132,900,000 -126,300,000 -27,500,000 -26,100,000 96,600,000 -25,600,000 -69,100,000 117,700,000 -122,800,000 -48,700,000 -151,100,000 -170,800,000 212,000,000  -37,300,000 21,400,000 -21,000,000  -72,100,000 -31,800,000 27,700,000  -27,400,000 -51,600,000 3,700,000  -10,600,000 -84,700,000 16,900,000 210,600,000 -70,600,000 -53,600,000 34,000,000  -38,700,000 -21,800,000 -3,400,000  26,900,000 -57,300,000 -35,300,000 -29,400,000 14,000,000 -467,000,000 1,712,000,000 -51,000,000 8,000,000 
      exchange rate effects on cash and cash equivalents
    		-2,600,000 19,600,000 7,900,000 -24,600,000 12,800,000 -5,200,000 -12,000,000 14,000,000 -10,000,000 -4,700,000 4,300,000 20,500,000 -18,200,000 -26,600,000 -1,500,000 -4,100,000 -9,300,000 1,200,000 -10,400,000 23,000,000 12,400,000 11,500,000 -11,700,000  -11,200,000 -100,000 700,000  -2,800,000 -16,800,000 8,200,000 -2,500,000 7,100,000 7,300,000 7,900,000  5,000,000 -5,900,000 9,900,000  -9,900,000 1,800,000 -15,800,000  -13,500,000 100,000 -1,700,000  6,100,000 4,800,000 1,500,000 -29,300,000 19,000,000 -4,000,000 -72,000,000 21,000,000 46,000,000 
      net cash – operating activities of discontinued operations
    		-200,000    -300,000 0 -100,000  0 -100,000 -100,000    -100,000  900,000 -100,000 -100,000  100,000 -100,000 200,000  -100,000 1,600,000 -400,000  -500,000 -200,000 -1,200,000  -300,000 -100,000 -800,000  -1,300,000 -900,000 7,500,000  1,600,000 -2,000,000 -300,000  -600,000 -4,100,000 -400,000           
      net change in cash and cash equivalents
    		48,600,000 28,200,000 700,000 -21,900,000 20,600,000 17,600,000 -66,200,000 58,200,000 -31,300,000 200,000 -99,100,000 46,600,000 -11,200,000 -184,700,000 62,900,000 61,500,000 7,000,000 -201,200,000 -79,600,000 77,500,000 -36,900,000 -20,700,000 227,800,000 56,200,000 23,500,000 -21,600,000 -7,400,000 35,200,000 76,200,000 10,900,000 48,900,000  40,300,000 6,800,000 -112,200,000 -15,100,000 42,500,000 2,400,000 15,200,000  7,500,000 -72,700,000 -13,900,000 61,400,000 -5,100,000 12,600,000 7,800,000  -37,100,000 -217,400,000 22,900,000 11,200,000 38,000,000 -1,170,000,000 1,526,000,000 86,000,000 42,000,000 
      cash and cash equivalents – beginning of year
    		0 0 440,000,000 0 0 0 489,900,000 0 0 0 561,900,000 0 0 0 648,300,000 0 0 0 860,600,000 0 0 0 612,900,000 0 0 0 562,200,000 0 0 0 391,000,000 0 0 0 460,700,000 0 0 0 415,700,000 0 0 0 584,000,000 0 0 0 507,300,000 0 0 -100,000 0 -100,000 690,000,000 -826,000,000 0 0 1,032,000,000 
      cash and cash equivalents – end of period
    		48,600,000 28,200,000 440,700,000  35,500,000 2,700,000 423,700,000  -31,300,000 200,000 462,800,000  -11,200,000 -184,700,000 711,200,000 61,500,000 7,000,000 -201,200,000 781,000,000 77,500,000 -36,900,000 -20,700,000 840,700,000 56,200,000 23,500,000 -21,600,000 554,800,000 35,200,000 76,200,000 10,900,000 439,900,000 -5,800,000 40,300,000 6,800,000 348,500,000 -15,100,000 42,500,000 2,400,000 430,900,000 -89,200,000 7,500,000 -72,700,000 570,100,000 61,400,000 -5,100,000 12,600,000 515,100,000  -37,100,000  22,900,000 11,100,000 728,000,000  1,526,000,000 86,000,000 1,074,000,000 
      supplemental disclosures of cash flow and non-cash information:
    		                                                         
      cash paid for interest
    		10,500,000 11,800,000 9,100,000 12,100,000 7,600,000 10,000,000 3,700,000                                                   
      cash paid for income taxes, net of refunds received
    		46,700,000 51,600,000 17,600,000 21,800,000 37,000,000 53,500,000 16,300,000                                                   
      capital expenditures included in current liabilities
    		-2,600,000 2,500,000 13,900,000                                                       
      less: cash classified within current assets held for sale
    		                                                         
      deferred income tax expense
    		                                                         
      (gain) loss on sale of businesses
    		                                                         
      gain on sale of long-lived assets
    		                                                         
      proceeds from sale of business
    		       1,000,000 0                                                 
      proceeds from sale of long-lived assets
    		                       -500,000                                  
      payments to acquire interest in unconsolidated subsidiaries
    		       -1,100,000 0   0 -500,000                                             
      net cash from discontinued operations – operating activities
    		                                                         
      cash and cash equivalents – end of year
    		                                                         
      capital expenditures included in accounts payable
    		     4,900,000 17,500,000                                                   
      long-term debt, repayments
    		     -38,800,000 -70,500,000     -1,000,000 0   -1,100,000 0 -1,200,000 -100,000 -1,200,000 -100,000    -100,000 -1,800,000 -200,000  -200,000 -400,000 -1,500,000  -400,000 -400,000 -300,000  -200,000                     
      cash paid during the year for:
    		                                                         
      asbestos-related (benefit) costs
    		               0      16,000,000 -40,700,000       13,500,000 -19,700,000                           
      contribution to divest asbestos-related assets and liabilities
    		                                                         
      (repayments of)/proceeds from commercial paper
    		                                                         
      supplemental disclosures of cash flow information
    		                                                         
      interest
    		        3,800,000 4,300,000 4,200,000 5,100,000 3,100,000 2,100,000 500,000 0 2,600,000 500,000 200,000 700,000 1,400,000 -1,100,000 2,300,000 300,000 500,000 700,000 1,000,000 2,300,000 -100,000 100,000 1,000,000 1,000,000 700,000 1,100,000 1,000,000 1,200,000 900,000 1,000,000 1,400,000 3,300,000 500,000         1,500,000 100,000   34,000,000 4,000,000 39,000,000 3,000,000 
      income taxes, net of refunds received
    		        19,200,000 39,600,000 13,200,000 29,200,000 18,300,000 36,700,000 8,500,000 11,100,000 7,900,000 28,900,000 13,400,000 20,200,000 30,200,000 2,700,000 8,000,000 15,500,000 14,200,000 24,400,000 9,300,000 22,500,000 7,800,000 16,200,000 7,000,000 22,400,000 17,700,000 8,700,000 13,200,000 18,900,000 22,000,000 10,200,000 5,000,000 23,800,000 18,000,000 7,700,000 -1,000,000   8,100,000 8,700,000 10,000,000 6,900,000 17,100,000 -28,500,000 10,500,000 -100,000,000     
      pension settlement charges
    		                                                         
      asset impairment charges
    		                   0 0 0 16,300,000                                   
      contributions to postretirement plans
    		                   -10,800,000                                      
      short-term revolving loans, borrowings
    		                   0 0 117,500,000 378,300,000     0 0 0 246,500,000 0 0   0 0 0 27,700,000                   
      short-term revolving loans, repayments
    		                   0 -118,500,000        -210,300,000    -23,900,000    0 -50,600,000 -27,700,000                   
      long-term debt, issued
    		                   0    1,000,000 0 0 7,100,000      0 1,800,000 2,100,000                       
      supplemental cash flow disclosures
    		                                                         
      asbestos-related benefit
    		                           15,400,000                              
      divestiture of asbestos-related assets and liabilities
    		                0                                         
      asbestos-related costs (benefit)
    		                  2,400,000 -50,400,000      11,800,000 12,600,000                               
      share repurchases from net settlement of employee stock incentive plans
    		             -100,000 -8,400,000                                           
      asbestos-related payments
    		               0 -10,400,000 -2,900,000 -1,600,000 -900,000 -1,300,000 -1,500,000 -6,100,000  -4,300,000 -5,900,000 -9,900,000  -11,500,000 -18,000,000 -12,800,000  -8,800,000 -17,700,000 -13,000,000  -13,000,000 -7,200,000 -4,300,000  -8,700,000 -2,600,000 -3,900,000  -2,000,000 -4,400,000 -2,500,000  -7,500,000 8,100,000 -11,900,000 -300,000 -16,000,000     
      repurchase of common stock
    		               -4,800,000 -50,300,000 -400,000 -61,000,000 -300,000 -200,000 -300,000 -83,400,000  -18,300,000 -100,000 -19,900,000  -400,000 -100,000 -55,300,000  -100,000 -30,500,000 -2,300,000  -43,400,000 -20,600,000 -6,900,000  -200,000 -900,000 -82,800,000  -10,600,000 -10,100,000 -4,800,000  0 -39,900,000 -100,000 -38,800,000 -38,000,000     
      proceeds from issuance of common stock
    		                  200,000 2,600,000 1,600,000 0 100,000 3,300,000 3,300,000 3,200,000 5,100,000 0 1,100,000 4,100,000 600,000 4,500,000 200,000 600,000 5,900,000 3,500,000 0 2,700,000 6,100,000 700,000 200,000 3,300,000 2,000,000               
      adjustments to income from continuing operations
    		                                                         
      deferred income tax (benefit) expense
    		                                                         
      (gain) loss on sale or disposal of long-lived assets
    		                                                         
      cash paid (received) during the year for:
    		                                                         
      commercial paper, net repayments
    		                      -82,700,000      146,400,000 0 -162,400,000                           
      gain on sale or disposal of long-lived assets
    		                                                         
      asbestos-related (benefit) cost
    		                                                         
      commercial paper, net (repayments) borrowings
    		                                                         
      non-cash lease expense
    		                          5,000,000                               
      proceeds from sale of businesses and other assets
    		                                   1,600,000 200,000   900,000 -300,000                 
      purchases of investments
    		                                    0 -20,600,000 -40,000,000  0 -57,700,000 -15,300,000  -44,500,000 -71,600,000 -49,000,000  -99,400,000         
      maturities of investments
    		                                   9,900,000 4,900,000 72,400,000 36,300,000 10,300,000 47,600,000 15,300,000 5,300,000 62,000,000 71,200,000 38,600,000 97,200,000 83,400,000 34,900,000         
      long-term debt issued
    		                                                         
      long-term debt, repaid
    		                                        -200,000 -1,700,000 -200,000  -500,000 -400,000 -300,000  -500,000  0       
      net income
    		                            111,100,000 69,900,000 101,300,000 -67,100,000 86,900,000 47,900,000 45,600,000 26,100,000 90,200,000 33,000,000 37,300,000 36,500,000 130,700,000 142,400,000 42,000,000 34,200,000 80,700,000 38,700,000 33,200,000 12,400,000 431,400,000 32,400,000 73,000,000 17,000,000 3,000,000 -500,000,000 78,000,000 168,000,000 124,000,000 
      less: income from discontinued operations
    		                             0 100,000  -100,000 -100,000 -100,000 2,200,000 1,800,000 500,000 -300,000 100,000 34,200,000 1,700,000 3,400,000  -300,000 -2,900,000 -1,000,000 300,000 -2,300,000 10,600,000 12,200,000 100,000 -7,000,000 443,000,000 7,000,000 0 -2,000,000 
      less: income attributable to noncontrolling interests
    		                            200,000 200,000 100,000  0   300,000 100,000      -100,000 500,000 400,000 400,000 1,000,000 1,200,000 700,000         
      change in accrued and deferred income taxes
    		                            17,700,000 -11,800,000 100,000  22,900,000 1,500,000 -4,600,000  23,600,000 6,300,000 3,400,000  -8,500,000 13,200,000 17,200,000  4,800,000 1,900,000 -1,700,000  -357,400,000  18,900,000 26,700,000 108,000,000     
      deferred income taxes
    		                                                         
      change in accrued income taxes
    		                                                         
      proceeds from insurance recovery
    		                                       1,700,000 0                 
      excess tax benefit from equity compensation activity
    		                                   -200,000 0 400,000 3,000,000 200,000 200,000 1,200,000 1,800,000 2,000,000 2,000,000 1,200,000 5,200,000 3,400,000 1,600,000         
      stock-based compensation
    		                                5,200,000 3,600,000 3,700,000  3,200,000 3,000,000 2,900,000  4,200,000 3,800,000 3,100,000 3,200,000 4,000,000 3,500,000 3,300,000 3,400,000 3,500,000 3,000,000 3,600,000 2,800,000 3,000,000 -10,000,000 7,000,000 8,000,000 7,000,000 
      proceeds from sale of assets
    		                                                         
      asbestos-related costs
    		                                 14,900,000 14,900,000    12,800,000   -84,800,000 15,400,000   15,900,000 15,800,000 16,300,000 -15,400,000 15,800,000 12,800,000 9,300,000 13,000,000     
      less: loss attributable to noncontrolling interests
    		                                  -400,000                       
      less: (loss) attributable to noncontrolling interests
    		                                      -100,000                   
      income from continuing operations attributable to itt corporation
    		                                      37,700,000 36,600,000 96,500,000 140,600,000 38,700,000 33,400,000 80,600,000 41,200,000 33,200,000 10,900,000 433,000,000         
      net cash – discontinued operations
    		                                                -14,700,000 -2,800,000 -3,400,000 1,500,000 -1,000,000     
      short-term debt
    		                                        -58,200,000 -44,800,000 113,500,000  -22,500,000 -4,500,000 -11,000,000 -28,100,000 26,200,000 -22,600,000 -40,000,000 16,800,000 21,000,000 -15,000,000 -46,000,000 -10,000,000 74,000,000 
      changes in assets and liabilities
    		                                                         
      proceeds from sale of discontinued operations and other assets
    		                                                 39,100,000 100,000       
      long-term debt repaid
    		                                                     -1,251,000,000    
      discontinued operations:
    		                                                         
      issuance of common stock
    		                                            2,900,000 2,400,000 9,000,000  6,100,000  4,500,000 700,000 35,000,000  7,000,000 8,000,000 33,000,000 
      interest paid
    		                                                         
      income taxes paid, net of
    		                                                         
      interest paid, net of interest received
    		                                             0 100,000  500,000         
      transformation costs
    		                                                 1,100,000 2,600,000 4,300,000 5,000,000    55,000,000 
      transformation-related payments
    		                                                 -3,100,000 -3,900,000 -10,300,000 -30,000,000     
      contributions from exelis and xylem
    		                                                         
      distributions of exelis and xylem
    		                                                         
      less: cash and cash equivalents distributed to exelis and xylem
    		                                                         
      cash and cash equivalents of continuing operations – end of period
    		                                                 -217,500,000 22,900,000 11,100,000 728,000,000     
      contributions to pension plans
    		                                                -800,000  -300,000 -800,000 -32,000,000     
      discontinued operations
    		                                                         
      income from continuing operations
    		                                                 21,800,000 60,800,000 16,900,000 10,000,000 -943,000,000 71,000,000 168,000,000 126,000,000 
      tax benefit from share-based compensation
    		                                                         
      less: cash and cash equivalents of discontinued operations – end of period
    		                                                         
      distribution of exelis and xylem
    		                                                         
      tax impact from equity compensation activity
    		                                                  500,000       
      restructuring and asset impairment charges
    		                                                         
      restructuring payments
    		                                                         
      income taxes
    		                                                     -29,000,000 16,000,000 136,000,000 17,000,000 
      non-cash adjustments to income from continuing operations:
    		                                                         
      non-cash transformation costs
    		                                                      9,000,000   
      proceeds from sale of assets and businesses
    		                                                         
      net cash from discontinued operations
    		                                                      0   
      payments for restructuring
    		                                                         
      change in accrued liabilities
    		                                                         
      change in accrued taxes
    		                                                         
      change in other assets
    		                                                         
      change in other liabilities
    		                                                         
      change in accrued and deferred taxes
    		                                                         
      net cash — operating activities
    		                                                         
      net cash — investing activities
    		                                                         
      tax impact from stock-based compensation
    		                                                         
      net cash — financing activities
    		                                                         
      cash and cash equivalents — beginning of period
    		                                                         
      cash and cash equivalents — end of period
    		                                                         
      cash paid during the period for:
    		                                                         
      tax benefit from stock option exercises and restricted stock award lapses
    		                                                         
      net cash – discontinued operations:
    		                                                         
      income from discontinued operations
    		                                                         
      change in other current and non-current assets
    		                                                         
      change in other current and non-current liabilities
    		                                                         
      tax impact from stock option exercises and restricted stock lapses
    		                                                         
      loss (income) from discontinued operations
    		                                                         
      change in accounts payable and accrued expenses
    		                                                         
      tax impact from stock option exercises and restricted stock award lapses
    		                                                         
      net cash — discontinued operations — operating activities
    		                                                         
      additions to plant, property and equipment
    		                                                         
      adjustments to reconcile income from continuing operations to net cash from operating activities:
    		                                                         
      change in non-current liabilities
    		                                                         
      additions to plant, property, and equipment
    		                                                         
      foreign exchange rate effects on cash and cash equivalents
    		                                                         
      net cash — discontinued operations:
    		                                                         
      cumulative effect of change in accounting principle
    		                                                         
      (income) income from discontinued operations
    		                                                         
      cash and cash equivalents — beginning of year
    		                                                         
      cash and cash equivalents — end of year
    		                                                         
      tax benefit from stock option exercises
    		                                                         
      (income) from discontinued operations
    		                                                         
      amortization of stock compensation
    		                                                         
      net cash — discontinued operations operating activities
    		                                                         
      net cash — discontinued operations investing activities
    		                                                         
      net cash — discontinued operations financing activities
    		                                                         
      supplemental disclosures of cash flow information:
    		                                                         
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.